SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-375630
Filing Date
2015-11-12
Accepted
2015-11-12 16:05:34
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d82772d10q.htm 10-Q 234778
2 EX-3.1 d82772dex31.htm EX-3.1 5954
3 EX-3.2 d82772dex32.htm EX-3.2 5745
4 EX-31.1 d82772dex311.htm EX-31.1 5776
5 EX-32.1 d82772dex321.htm EX-32.1 3005
  Complete submission text file 0001193125-15-375630.txt   1934182

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxii-20150930.xml EX-101.INS 271806
7 XBRL TAXONOMY EXTENSION SCHEMA rxii-20150930.xsd EX-101.SCH 21657
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20150930_cal.xml EX-101.CAL 36451
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20150930_def.xml EX-101.DEF 92505
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20150930_lab.xml EX-101.LAB 221252
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20150930_pre.xml EX-101.PRE 162979
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 151224808
SIC: 2834 Pharmaceutical Preparations